Paritosh Dhawale
Directeur/Membre du Conseil chez OncoNano Medicine, Inc.
Provenance du réseau au premier degré de Paritosh Dhawale
Entité | Type d'entité | Industrie | |
---|---|---|---|
OncoNano Medicine, Inc.
OncoNano Medicine, Inc. BiotechnologyHealth Technology OncoNano Medicine, Inc. operates as a biotechnology company. It develops pH-activated compounds that digitalize and exploit the variability of pH in disease. The company was founded by Ravi Srinivasan, Jinming Gao, and Baran Sumer in 2014 and is headquartered in Southlake, TX.
4
| Holding Company | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Paritosh Dhawale via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BIOLIFE SOLUTIONS, INC. | Medical Specialties | Director/Board Member | |
ILLUMINA, INC. | Biotechnology | Director of Finance/CFO | |
Salem Partners LLC
Salem Partners LLC Investment ManagersFinance Salem Partners LLC. provides investment banking services. Its services include valuation services, media and entertainment, healthcare and life sciences, aerospace, defense and government services, real estate and transactions. The company was founded by John Dyett and Stephen Prough in 1997 and is headquartered in Los Angeles, CA. | Investment Managers | Chief Executive Officer | |
Q Therapeutic Products, Inc.
Q Therapeutic Products, Inc. Miscellaneous Commercial ServicesCommercial Services Q Therapeutic Products, Inc. develops novel products to treat debilitating and fatal diseases. The company was founded by Dennis B. Farrar and Mahendra S. Rao in 2004 and is headquartered in Salt Lake, UT. | Miscellaneous Commercial Services | Director/Board Member | |
FEMASYS INC. | Electronic Equipment/Instruments | Director/Board Member | |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Director/Board Member | |
MEDLEY MANAGEMENT INC. | Investment Managers | Director/Board Member | |
University of Virginia | College/University | Undergraduate Degree | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
University of Arizona | College/University | Corporate Officer/Principal | |
THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal | |
Esperance Pharmaceuticals, Inc.
Esperance Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Esperance Pharmaceuticals, Inc. develops oncology products. It specializes in oncology products that selectively kill cancer cells without harming normal cells. The company was founded by Hector W. Alila in 2006 and is headquartered in Baton Rouge, LA. | Pharmaceuticals: Major | Director/Board Member | |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Middlesex School | College/University | Director/Board Member | |
The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
Life Technologies Japan Ltd. | President | ||
Indian Institute of Technology Bombay | College/University | Undergraduate Degree | |
TMune Therapeutics, Inc.
TMune Therapeutics, Inc. BiotechnologyHealth Technology TMune Therapeutics, Inc. provides cancer treatment research and technology development services. It focuses on the development of T-cell therapies for the treatment of cancer and infectious diseases. The firm's proprietary cell activation technology is used and administered in patients, who are undergoing treatment for leukemia, lymphoma, and HIV. The company was founded by Louis P. Berneman in 2008 and is headquartered in Greenwich, CT. | Biotechnology | Director/Board Member | |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
Salem Partners Wealth Management LLC
Salem Partners Wealth Management LLC Investment ManagersFinance Part of Salem Partners LLC, Salem Partners Wealth Management LLC is a company that provides investment advice. The company is based in Los Angeles, CA. John Hathaway Dyett has been the CEO of the company since 2004. | Investment Managers | Chief Executive Officer | |
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Spectrix Therapeutics LLC is a privately held specialty pharmaceutical company. It provide and develops St-ME01, and ST-RHU02. The company was founded by Mark Tengler, John Q. Adams Jr., and John Dyett in 2016 and is headquartered in Southlake, TX. | Pharmaceuticals: Major | Founder | |
ARCUS BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Columbia University Vagelos College of Physicians & Surgeons | College/University | Doctorate Degree | |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | Biotechnology | Chief Executive Officer | |
Revelar Biotherapeutics, Inc.
Revelar Biotherapeutics, Inc. BiotechnologyHealth Technology Revelar Biotherapeutics is a biopharmaceutical company based in Bethesda, MD. Revelar Biotherapeutics, Inc. focuses on developing and commercializing breakthrough therapeutic antibody products to address critical unmet patient needs, particularly in the field of COVID-19 and other therapeutic areas. The company's management team has extensive expertise in clinical development, regulatory affairs, business development, and operations with leading pharmaceutical companies. Revelar was spun out of Twist Bioscience in November 2021 and has the ability to leverage Twist Biopharma's antibody discovery and optimization platform to license additional antibodies for non-COVID targets. The company's therapeutic areas of interest include oncology and infectious diseases. Revelar aims to combine its clinical development and commercialization capabilities with Twist's innovative technology platform and industry and academia collaborations to accelerate the discovery and delivery of transformative antibody therapeutics to meet patients' unmet needs. Revelar was founded by Kevin P. Malobisky, and the CEO is Glenn Marina. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 29 |
Japon | 2 |
Inde | 2 |
Sectorielle
Health Technology | 12 |
Consumer Services | 8 |
Finance | 5 |
Commercial Services | 5 |
Electronic Technology | 3 |
Opérationnelle
Director/Board Member | 17 |
Corporate Officer/Principal | 7 |
Chief Executive Officer | 4 |
Independent Dir/Board Member | 4 |
Undergraduate Degree | 4 |
Relations les plus connectées
Insiders | |
---|---|
Joydeep Goswami | 13 |
John Dyett | 10 |
Brett P. Giroir | 7 |
Kartik Krishnan | 5 |
- Bourse
- Insiders
- Paritosh Dhawale
- Connexions Sociétés